ANDA 203322

MYLAN LABS LTD

FDA Drug Application

Application #203322

Application Sponsors

ANDA 203322

MYLAN LABS LTD

Marketing Status

• Discontinued: 001

Application Products

001

INJECTABLE;SUBCUTANEOUS

EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

0

SUMATRIPTAN SUCCINATE

SUMATRIPTAN SUCCINATE

FDA Submissions

UNKNOWN;

ORIG

1

AP

2014-04-14

Submissions Property Types

ORIG

1

Null

15

CDER Filings

MYLAN LABS LTD

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203322
            [companyName] => MYLAN LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"SUMATRIPTAN SUCCINATE","activeIngredients":"SUMATRIPTAN SUCCINATE","strength":"EQ 6MG BASE\/0.5ML (EQ 12MG BASE\/ML)","dosageForm":"INJECTABLE;SUBCUTANEOUS","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/14\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2014-04-14
        )

)